FULC
Fulcrum Therapeutics Inc
3.80$
-0.5%
vs. previous close
Closing price · As of: Sep 17, 2026
Filings
Filings
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Fulcrum Therapeutics Inc (FULC) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 09/02/2026 | Insider sale notice | Form 144 filed with the SEC | View document ↗ |
| 08/17/2026 | Current report (8-K) | Fulcrum Therapeutics, Inc. (FULC): Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits | View report ↗ |
| 08/14/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 08/10/2026 | Current report (8-K) | Fulcrum Therapeutics, Inc. (FULC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers | View report ↗ |
| 08/03/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
| 07/17/2026 | Ownership disclosure | Form SC 13G filed with the SEC | View document ↗ |
Showing the 100 most recent filings of the selected type.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.